Our ambition
for 2030
Our 2030 ambition
The Servier 2030 ambition expresses what the Group wants to be in 2030
Our 2030 strategy fulfils our vocation and takes account of the health challenges facing society today and into the future. We are driven to achieve our ambition as cancer is ever-more prevalent and cardiometabolic diseases still represent a major cause of death around the world.
This is our vision.
Then, our ambition for 2030 is to be:
Our Vocation
Committed to therapeutic progress to serve patient needs
Our Values
Our Vision
Founded to serve health, our Group aspires to make a meaningful social impact for patients and for a sustainable world.
Challenges and opportunities of being a mid-size pharma player
Can a medium-sized pharmaceutical company be competitive and resilient in such a competitive and constantly evolving environment? To answer this question, Insights’ editorial team interviewed Mathieu Lamiaux, managing director and senior partner at Boston Consulting Group, and Jérôme Klein, head of corporate strategy at Servier.
